Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calorie restriction extends lifespan and produces a metabolic profile desirable for treating diseases of ageing such as type 2 diabetes. SIRT1, an NAD+-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produce beneficial effects on glucose homeostasis and insulin sensitivity. Resveratrol, a polyphenolic SIRT1 activator, mimics the anti-ageing effects of calorie restriction in lower organisms and in mice fed a high-fat diet ameliorates insulin resistance, increases mitochondrial content, and prolongs survival. Here we describe the identification and characterization of small molecule activators of SIRT1 that are structurally unrelated to, and 1,000-fold more potent than, resveratrol. These compounds bind to the SIRT1 enzyme-peptide substrate complex at an allosteric site amino-terminal to the catalytic domain and lower the Michaelis constant for acetylated substrates. In diet-induced obese and genetically obese mice, these compounds improve insulin sensitivity, lower plasma glucose, and increase mitochondrial capacity. In Zucker fa/fa rats, hyperinsulinaemic-euglycaemic clamp studies demonstrate that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver. Thus, SIRT1 activation is a promising new therapeutic approach for treating diseases of ageing such as type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, we show that recently developed SIRT1 activators, which are effective in improving energy homeostasis and decreasing hepatosteatosis in mouse models (Milne et al. 2007;Feige et al. 2008), also increase ubiquitination and proteasomal targeting of SREBP-1a, resulting in decreased SREBP-1 nuclear levels and target gene expression.”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Milne et al. 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent studies have reported the identification of potent SIRT1-activating compounds, and showed that such SIRT1 activators could significantly ameliorate insulin resistance and improve energy homeostasis in mouse diet-induced obesity models (Milne et al. 2007).”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Milne et al. 2007
In the citing paper
“In contrast to these negative regulators of insulin action, SIRT1 appears to be a positive regulator of insulin sensitivity (43,44).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [43]
In the citing paper
“Additionally, the non-naturally occurring sirtuin-activating compound, SRT1720, has enhanced insulin sensitivity and oxidative metabolism in animal models of obesity, in part, by improving mitochondrial oxidative capacity231.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [231]
In the citing paper
“Other related small molecules are more potent than resveratrol to enhance the action of SIRT1 on substrates for deacetylation (218). These compounds also improve insulin sensitivity in obese rodents (218).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [218]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Self-citationLagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Self-citationSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Self-citationTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Self-citationSirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Self-citation
Cited by
Items 801–900 of 1,004
In Search of New Therapeutic Targets in Obesity Treatment: Sirtuins
Kurylowicz, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040572 · Cited by 42
Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors
Kutil, Z., Mikešová, J., Zessin, M., Meleshin, M., Nováková, Z., Alquicer, G., Kozikowski, A., Sippl, W., Bařinka, C., & Schutkowski, M. (2019) · ACS Omega · doi:10.1021/acsomega.9b02808 · Cited by 39
Role of dietary modifications in the management of type 2 diabetic complications
Oza, M. J., Laddha, A. P., Gaikwad, A. B., Mulay, S. R., & Kulkarni, Y. A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105602 · Cited by 45
Sirtuins are not conserved longevity genes
Brenner, C. (2022) · Life Metabolism · doi:10.1093/lifemeta/loac025 · Cited by 46
“A group at Sirtris and Harvard claimed direct Sirt1 activators with 1000 times the potency of resveratrol and biological activity in rodent models of diabesity 71 .”
BackgroundFu, L., Bruckbauer, A., Li, F., Cao, Q., Cui, X., Wu, R., Shi, H., Zemel, M. B., & Xue, B. (2015) · Metabolism · doi:10.1016/j.metabol.2015.03.007 · Cited by 44
“[15] Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, et al.”
BackgroundGesing, A., Masternak, M. M., Wang, F., Joseph, A.-M., Leeuwenburgh, C., Westbrook, R., Lewiñski, A., Karbownik‐Lewińska, M., & Bartke, A. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr080 · Cited by 41
“Interestingly, SIRT-1 activators improved insulin sensitivity in obese mice as well as in fatty Zucker rats and even are considered as a potential medicament for treating type 2 diabetes (57).”
BackgroundSirt1-Independent Mechanisms of the Putative Sirtuin Enzyme Activators SRT1720 and SRT2183
Huber, J. L., McBurney, M. W., DiStefano, P. S., & McDonagh, T. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.257 · Cited by 41
Up-Regulation of SIRT1 Reduces Endoplasmic Reticulum Stress and Renal Fibrosis
Chang, J. W., Kim, H., Baek, C. H., Lee, R. B., Yang, W. S., & Lee, S. K. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447067 · Cited by 43
Chen, X., Sun, W., Huang, S., Zhang, H., Lin, G., Li, H., Qiao, J., Li, L., & Yang, S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01183 · Cited by 42
Frailty and HIV: Moving from Characterization to Intervention
Erlandson, K. M., & Piggott, D. A. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00554-1 · Cited by 46
PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity
Caito, S. W., Hwang, J.-W., Chung, S., Yao, H., Sundar, I. K., & Rahman, I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.161 · Cited by 43
“SRT1720 was synthesized by Life Chemicals (Ottawa, Canada) with >95% purity measured by GCmass spectrometry, as previously described [8].”
Savio, M., Coppa, T., Bianchi, L., Vannini, V., Maga, G., Forti, L., Cazzalini, O., Lazzè, M. C., Perucca, P., Prosperi, E., et al. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.08.005 · Cited by 41
“In addition, RSV seems to be effective in increasing the lifespan of various organisms, from yeast to small mammals (Howitz et al., 2003; Baur et al., 2006; Barger et al., 2008) and in delaying the onset of a variety of age-related diseases, such as diabetes (Milne et al., 2007).”
BackgroundWu, J., Zhang, D., Chen, L., Li, J., Wang, J.-L., Ning, C., Yu, N., Zhao, F., Chen, D., Chen, X., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301032j · Cited by 47
Nampt and Its Potential Role in Inflammation and Type 2 Diabetes
Garten, A., Petzold-Quinque, S., Schuster, S., Körner, A., Kratzsch, J., & Kieß, W. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_7 · Cited by 42
Terpenylated Coumarins As SIRT1 Activators Isolated from Ailanthus altissima
Đào, T. T., Tran, T.-L., Kim, J., Nguyen, P.-H., Lee, E. H., Park, J., Jang, I., & Oh, W. K. (2012) · Journal of Natural Products · doi:10.1021/np300258u · Cited by 42
Botham, R. C., Fan, T. M., Im, I., Borst, L. B., Dirikolu, L., & Hergenrother, P. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja4124303 · Cited by 40
Gilbert, R. E., Thai, K., Advani, S. L., Cummins, C. L., Kepecs, D. M., Schroer, S. A., Woo, M., & Zhang, Y. (2015) · Diabetologia · doi:10.1007/s00125-014-3485-4 · Cited by 41
“For instance, administration of SRT1720 reduced blood glucose in high-fat diet fed, obese Lep mice and while they did not gain weight, the mice received the drug for only 1 week [45].”
BackgroundLiu, X., Hu, D., Zeng, Z., Zhu, W., Zhang, N., Yu, H., Chen, H., Wang, K., Wang, Y., Wang, L., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.107 · Cited by 43
“As the natural compound resveratrol was identified as a SIRT1 activator, a large number of small molecules have been found to activate SIRT1 (refs 17,18 of which SRT1720 is the most effective and specific one.(19) SRT1720 treatment extends the lifespan of both healthymice and those on high fat diets,(20,21) and can am…”
BackgroundNishida, K., Matsushita, T., Takayama, K., Tanaka, T., Miyaji, N., Ibaraki, K., Araki, D., Kanzaki, N., Matsumoto, T., & Kuroda, R. (2018) · Bone and Joint Research · doi:10.1302/2046-3758.73.bjr-2017-0227.r1 · Cited by 40
Zabihi, A., Shabankareh, H. K., Hajarian, H., & Foroutanifar, S. (2019) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2018.12.010 · Cited by 42
Zhu, X., Wang, F., Lei, X., & Dong, W. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220975106 · Cited by 39
“This indicates that the mitochondrial-dependent apoptotic pathway is involved in hyperoxia injury.49 In the study of hyperoxia-induced lung injury, SRT1720 may play a similar role as Res.19,20 EX-527 can effectively inhibit SIRT1 deacetylase activity and thus restore global acetylation levels.21 In this study, we furt…”
BackgroundInfluentialAging affects circadian clock and metabolism and modulates timing of medication
Sadria, M., & Layton, A. T. (2021) · iScience · doi:10.1016/j.isci.2021.102245 · Cited by 45
Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders
Leite, J. A., Ghirotto, B., Targhetta, V. P., de Lima, J., & Câmara, N. O. S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15570 · Cited by 45
“A more recent class of molecules also capable of activating SIRT1 in a more specific way are the SRT compounds, such as SRT1720 (Milne et al., 2007), SRT2104 (compound 4, GSK2245840 or SRT-210) (Hoffmann et al., 2013; Jiang et al., 2017) and SRT3025 (Miranda et al., 2015) that have been used in…”
BackgroundAi, W., Wei, X., Lin, X., Li, S., Wang, Z., Tu, Z., Yang, X., Zhou, X., Li, J., & Liu, Y. (2014) · Tetrahedron · doi:10.1016/j.tet.2014.06.041 · Cited by 40
Chini, C. C. S., Espíndola‐Netto, J. M., Mondal, G., Guerrico, A. M. G., Nin, V., Escande, C., Sola‐Penna, M., Zhang, J., Billadeau, D. D., & Chini, E. N. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1760 · Cited by 45
“The only exception was combination of gemcitabine and SRT1460 in Patu8988t, which was not more effective than SRT1460 alone.”
BackgroundInfluentialSIRT1 Suppresses Human T-Cell Leukemia Virus Type 1 Transcription
Tang, H.-M. V., Gao, W., Chan, C., Cheng, Y., Deng, J.-J., Yuen, K., Iha, H., & Jin, D. (2015) · Journal of Virology · doi:10.1128/jvi.01229-15 · Cited by 41
Cardiovascular determinants of life span
Shi, Y., Camici, G. G., & Lüscher, T. F. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0727-2 · Cited by 41
“Resveratrol increases insulin secretion in pancreatic β cells [ 68 ] and improves endothelial function in the aorta of diabetic mouse [76].”
BackgroundRao, R. M., Upendar Reddy, C. H., Nakhi, A., Mulakayala, N., Alvala, M., Arunasree, M. K., Poondra, R. R., Javed Iqbal, M., & Pal, M. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob01161d · Cited by 39
Absolute structures of C-glucosides of resveratrol oligomers from Shorea uliginosa
Ito, T., Abe, N., Oyama, M., & Iinuma, M. (2009) · Tetrahedron Letters · doi:10.1016/j.tetlet.2009.03.043 · Cited by 39
Houillé, B., Besseau, S., Delanoue, G., Oudin, A., Papon, N., Clastre, M., Simkin, A. J., Guérin, L., Courdavault, V., Giglioli‐Guivarc’h, N., et al. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b02997 · Cited by 42
Nguyen, L. T., Chen, H., Zaky, A. A., Pollock, C. A., & Saad, S. (2018) · The Journal of Physiology · doi:10.1113/jp276957 · Cited by 44
“Conversely, overexpression of SIRT1 mimics caloric restriction (Wood et al. 2004), leading to a longer lifespan and resistance to obesity-related disorders in various animal models (Wood et al. 2004; Milne et al. 2007; Pfluger et al. 2008).”
BackgroundOne-Atom Substitution Enables Direct and Continuous Monitoring of Histone Deacylase Activity
Zessin, M., Kutil, Z., Meleshin, M., Nováková, Z., Ghazy, E., Kalbas, D., Marek, M., Romier, C., Sippl, W., Bařinka, C., et al. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00786 · Cited by 37
Cellulose-based Biosensor for Bio-molecules Detection in Medical Diagnosis: A Mini-Review
Chang, M., Song, T., Liu, X., Lin, Q., He, B. H., & Ren, J. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200221145543 · Cited by 40
Resistant dextrin improves high-fat-high-fructose diet induced insulin resistance
Hu, F., Niu, Y., Xu, X., Hu, Q., Su, Q., & Zhang, H. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00450-2 · Cited by 43
Sirtuin Modulators in Cellular and Animal Models of Human Diseases
Hong, J. Y., & Lin, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.735044 · Cited by 44
“Because SIRT1 was initially connected to longevity, many smallmolecule activators have been developed and tested for anti-aging purposes (Howitz et al., 2003; Borra et al., 2005; Milne et al., 2007).”
BackgroundRowlands, B. D., Klugmann, M., & Rae, C. D. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13916 · Cited by 38
“5 of 37 lmol/L for SIRT2 (Milne et al. 2007; Pacholec et al. 2010) while it acts as an inhibitor at SIRT3 (IC50 = 11 lmol/L) (Nguyen et al. 2013).”
BackgroundInfluentialResveratrol ameliorates muscle atrophy in chronic kidney disease via the axis of SIRT1/FoxO1
Wang, R., Yuan, W., Li, L., Lu, F., Zhang, L., Gong, H., & Huang, X. (2022) · Phytotherapy Research · doi:10.1002/ptr.7499 · Cited by 42
Cui, S., Hu, H., Chen, A., Cui, M., Pan, X., Zhang, P., Wang, G., Wang, H., & Hao, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.019 · Cited by 41
Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders
Sorriento, D., Pascale, A. V., Finelli, R., Carillo, A. L., Annunziata, R., Trimarco, B., & Iaccarino, G. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/604685 · Cited by 43
“Other related small molecules are more potent than resveratrol to enhance the action of SIRT1 on substrates for deacetylation [114].”
BackgroundRetractedZou, X., Guo, S.-Q., Hu, Z., & Li, W. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5034 · Cited by 40
Ismail, Kuthati, B., Thalari, G., Bommarapu, V., Mulakayala, C., Chitta, S. K., & Mulakayala, N. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.01.088 · Cited by 41
Tian, Y., Wei, L., Shi, J., Jiang, K., Xu, H., Hu, L., Kong, L., Zhang, Y., Meng, S., & Piao, H. (2019) · BMC Cancer · doi:10.1186/s12885-019-5852-5 · Cited by 40
Caloric restriction mimetics for the treatment of cardiovascular diseases
Sciarretta, S., Forte, M., Castoldi, F., Frati, G., Versaci, F., Sadoshima, J., Kroemer, G., & Maiuri, M. C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa297 · Cited by 41
Epigenetic Regulation Associated With Sirtuin 1 in Complications of Diabetes Mellitus
Wang, J., Wang, S., Wang, J., Xiao, M., Guo, Y., Tang, Y., Zhang, J., & Gu, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.598012 · Cited by 44
The Pleiotropic Function of Human Sirtuins as Modulators of Metabolic Pathways and Viral Infections
Alqarni, M. H., Foudah, A. I., Muharram, M. M., & Labrou, N. E. (2021) · Cells · doi:10.3390/cells10020460 · Cited by 47
“Intense research effort focuses on the design and synthesis of more potent and efficient resveratrol-like analogues with increased bioavailability [103,104].”
BackgroundVitamin B3, the nicotinamide adenine dinucleotides and aging
Xu, P., & Sauve, A. A. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.03.006 · Cited by 42
Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review
Pulla, V. K., Battu, M. B., Alvala, M., Sriram, D., & Yogeeswari, P. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.703656 · Cited by 40
Kumar, R. K., Nigam, L., Singh, A. P., Singh, K. K., Subbarao, N., & Dey, S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.001 · Cited by 41
New insights into Sirt1: potential therapeutic targets for the treatment of cerebral ischemic stroke
Tang, H., Wen, J., Qin, T., Chen, Y., Huang, J., Yang, Q., Jiang, P., Wang, L., Zhao, Y., & Yang, Q. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1228761 · Cited by 40
“Similar to resveratrol, SRT1720 binds to the Sirt1-substrate complex at the allosteric site of the amino terminal catalytic region, thereby promoting Sirt1 deacetylation activity (Milne et al., 2007).”
BackgroundSirT1 brings stemness closer to cancer and aging
Calvanese, V., & Fraga, M. F. (2011) · Aging · doi:10.18632/aging.100272 · Cited by 39
“Clinical trials are under way to test the therapeutic potential of sirtuin activators in conditions such as type 2 diabetes [53].”
BackgroundThe Role of Sirtuin-1 in Immune Response and Systemic Lupus Erythematosus
Qiu, Y., Zhou, X., Liu, Y. S., Tan, S., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632383 · Cited by 40
“This compound could stimulate 750% SIRT1 activity at 10μM (34).”
BackgroundInsulin resistance in glomerular podocytes: Potential mechanisms of induction
Rogacka, D. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.109005 · Cited by 40
Mayers, J. R., Iliff, B. W., & Swoap, S. J. (2008) · The FASEB Journal · doi:10.1096/fj.08-115923 · Cited by 43
“Other purported Sirt1 activators, structurally distinct from resveratrol, have also shown promise as treatments for type 2 diabetes in mice (31).”
BackgroundYu, F., Wu, J., Chen, L., Luo, C., Shen, X., Chen, K., Jiang, H., & Liu, D. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.08.011 · Cited by 40
“In addition, mass spectrometry and capillary electrophoresis have also been employed to determine the effects of compounds on SIRT1 activity [15,16].”
BackgroundMethodLakshminarasimhan, M., Curth, U., Moniot, S., Mosalaganti, S., Raunser, S., & Steegborn, C. (2013) · Bioscience Reports · doi:10.1042/bsr20120121 · Cited by 42
Zeng, K., Feng, Q.-G., Lin, B.-T., Ma, D., & Liu, C. (2017) · Bioscience Reports · doi:10.1042/bsr20170695 · Cited by 39
RetractedSRT1720, a sirtuin 1 activator, attenuates organ injury and inflammation in sepsis
Khader, A., Yang, W.-L., Hansen, L. W., Rajayer, S. R., Prince, J. M., Nicastro, J. M., Coppa, G. F., & Wang, P. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.06.031 · Cited by 37
Mitochondrion: A bridge linking aging and degenerative diseases
Zhang, L., Wu, J., Zhu, Z., He, Y., & Fang, R. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121666 · Cited by 40
Ligand and structure-based approaches for the identification of SIRT1 activators
Vyas, V. K., Goel, A., Ghate, M. D., & Patel, P. N. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.01.001 · Cited by 36
Zemel, M., Fu, L., Li, F., Bruckbauer, A., Cao, Q., Wu, R., Shi, H., Xue, B., & Cui, X. (2015) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s82338 · Cited by 36
Charles, S., Raj, V. S., Arockiaraj, J., & Mala, K. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.022 · Cited by 37
Feng, T., Liu, P., Wang, X., Luo, J., Zuo, X., Jiang, X., Liu, C., Li, Y., Li, N., Chen, M., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.04.039 · Cited by 35
Novel targets for delaying aging: The importance of the liver and advances in drug delivery
Hunt, N. J., McCourt, P., Couteur, D. G. L., & Cogger, V. C. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.006 · Cited by 39
Ma, L., Wang, R., Wang, H., Zhang, Y., & Zhao, Z. (2020) · Food & Nutrition Research · doi:10.29219/fnr.v64.3668 · Cited by 43
“Furthermore, administration of the SIRT1 activator in mice fed with a high-fat diet results in development of resistance toward weight gain and insulin resistance caused by a high-fat diet (16, 17).”
BackgroundBrezoiu, A.-M., Băjenaru, L., Berger, D., Mitran, R., Deaconu, M., Lincu, D., Stoica‐Guzun, A., Matei, C., Moisescu, M. G., & Negreanu–Pîrjol, T. (2020) · Antioxidants · doi:10.3390/antiox9080696 · Cited by 38
“Resveratrol exhibited anti-diabetes potential at rats, modulating the gene involved in the blood homeostasis [28].”
BackgroundDeciphering therapeutic options for neurodegenerative diseases: insights from SIRT1
Wang, R., Wu, Y., Liu, R., Liu, M., Li, Q., Ba, Y., & Huang, H. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02187-2 · Cited by 39
“High-throughput screening of small molecules identified three sirt1-activating molecules, SRT1460 and SRT1720, which are structurally unrelated to resveratrol with a 1000-fold increase in potency [234].”
BackgroundSirtuins, aging, and cardiovascular risks
Favero, G., Franceschetti, L., Rodella, L. F., & Rezzani, R. (2015) · AGE · doi:10.1007/s11357-015-9804-y · Cited by 37
Ceolotto, G., de Kreutzenberg, S. V., Cattelan, A. M., Fabricio, A. S. C., Squarcina, E., Gion, M., Semplicini, A., Fadini, G. P., & Avogaro, A. (2014) · Clinical Science · doi:10.1042/cs20130439 · Cited by 40
Cen, Y., & Sauve, A. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910342d · Cited by 39
Sirt1’s Complex Roles in Neuroprotection
Tang, B. L. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9414-2 · Cited by 41
“Accordingly, resveratrol administration improves health and survival of animal on a high calorie diet (Baur et al. 2006), and Sirt1 activators are effective as experimental therapeutics in animal models of type II diabetes (Milne et al. 2007).”
Perspectives of Targeting mTORC1–S6K1 in Cardiovascular Aging
Ming, X., Montani, J., & Yang, Z. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00005 · Cited by 38
Energy Restriction for Breast Cancer Prevention
Howell, A., Chapman, M., & Harvie, M. (2008) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-69297-3_11 · Cited by 35
SRT1720 counteracts glucosamine-induced endoplasmic reticulum stress and endothelial dysfunction
Fiorentino, T. V., Procopio, T., Mancuso, E., Arcidiacono, G. P., Andreozzi, F., Arturi, F., Sciacqua, A., Perticone, F., Hribal, M. L., & Sesti, G. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv169 · Cited by 35
Tomada, I., Tomada, N., Almeida, H., & Neves, D. (2011) · AGE · doi:10.1007/s11357-011-9328-z · Cited by 36
Resveratrol derivatives: a patent review (2009 – 2012)
Pezzuto, J. M., Kondratyuk, T. P., & Ogas, T. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.834888 · Cited by 35
Jiao, J., Bae, E. J., Bandyopadhyay, G. K., Oliver, J., Marathe, C., Chen, M. J., Hsu, J.-Y., Chen, Y., Tian, H., Olefsky, J. M., et al. (2012) · Diabetes · doi:10.2337/db12-0681 · Cited by 37
“insulinemic-euglycemic clamp procedures were conducted as previously described with minor modifications (10).”
MethodSelf-citationSuzuki, S., Iben, J., Coon, S. L., & Kino, T. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.012 · Cited by 36
Jana, S., Chakraborty, A., Ширинян, В. З., & Hajra, A. (2018) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201800393 · Cited by 35
Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism
Karwi, Q. G., Joerg, A. R., & Lopaschuk, G. D. (2019) · Biochemical Journal · doi:10.1042/bcj20180617 · Cited by 42
Sreng, N., Champion, S., Martin, J., Khelaifia, S., Christensen, J. E., Padmanabhan, R., Azalbert, V., Blasco‐Baqué, V., Loubières, P., Pechère, L., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108218 · Cited by 34
Sinha, S., Sharma, S., Vora, J., & Shrivastava, N. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104880 · Cited by 39
Phenolic molecules constructed nanomedicine for innovative cancer treatment
Li, Q., Dong, Z., Chen, M., & Feng, L. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.213912 · Cited by 36
The Beneficial Role of Exercise on Treating Alzheimer’s Disease by Inhibiting β-Amyloid Peptide
Tan, Z., Dong, F., Wu, L., Feng, Y.-S., & Zhang, F. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02514-7 · Cited by 40
Effects ofPolygonatum sibiricumrhizome ethanol extract in high-fat diet-fed mice
Ko, J.-H., Kwon, H.-S., Yoon, J., Yoo, J.-S., Jang, H.-S., Kim, J., Yeon, S.-W., & Kang, J. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2014.932393 · Cited by 37
“Resveratrol, a SIRT1 activator, is a well-known potential therapy for insulin resistance-related conditions, such as type 2 diabetes mellitus and metabolic syndrome, and exerts antiaging effects by mimicking calorie restriction (Milne et al., 2007).”
BackgroundThe role of transcriptional regulators in central control of appetite and body weight
Coppari, R., Ramadori, G., & Elmquist, J. K. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1070 · Cited by 40
SIRT1: A novel target to prevent atherosclerosis
Yu, W., Fu, Y., Chen, C., Wang, X., & Wang, W. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22240 · Cited by 38
The importance of epigenetics in the development of chronic obstructive pulmonary disease
Sakao, S., & Tatsumi, K. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02032.x · Cited by 40
Epigenetics, sirtuins and osteoarthritis
Gabay, O., & Sanchez, C. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.04.005 · Cited by 34
Gu, C., Li, Y., Xu, W., Yan, J., Xia, Y., Ma, Y., Chen, C., Wang, H., & Tao, H. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.974740 · Cited by 36
“On the one hand, the therapeutic eff ects of SRT1720 have been investigated in several diseases such as infl ammation in asthma (12), diabetes (13, 14), cardiovascular disease (15), kidney injury (16) and COPD (17, 18).”
BackgroundXiao, C., Zou, Y., Du, J.-L., Sun, H.-Y., & Liu, X. (2012) · Synthetic Communications · doi:10.1080/00397911.2010.538889 · Cited by 34
“[ 4 ] 3-Arylcoumarins, which belong to a minor class of naturally derived isoflavonoids, were scarcely documented previously in terms of bioactivity and structure modifications.”
BackgroundCatalysis and Mechanistic Insights into Sirtuin Activation
Dittenhafer‐Reed, K. E., Feldman, J. L., & Denu, J. M. (2010) · ChemBioChem · doi:10.1002/cbic.201000434 · Cited by 40
Introduction: Sirtuins in Aging and Diseases
Guarente, L. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-637-5_1 · Cited by 37
Stefanowicz, M., Nikołajuk, A., Matulewicz, N., & Karczewska‐Kupczewska, M. (2018) · Endocrine · doi:10.1007/s12020-018-1544-1 · Cited by 36
Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer
Rifai, K. T., Idrissou, M., Penault-Llorca, F. M., Bignon, Y., & Bernard-Gallon, D. J. (2018) · Cancers · doi:10.3390/cancers10110409 · Cited by 35
“These STACs are currently being used as SIRT1 activators in breast cancer studies; they include among others SRT1460, SRT1720, SRT2104, and SRT2183 [86,87,91].”
BackgroundGhemrawi, R., Arnold, C., Battaglia-Hsu, S.-F., Pourié, G., Trinh, I., Bassila, C., Rashka, C., Wiedemann, A., Flayac, J., Robert, A., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153992 · Cited by 34
Hao, R., Song, X., Sun‐Waterhouse, D., Tan, X., Li, F., & Li, D. (2021) · Environmental Pollution · doi:10.1016/j.envpol.2021.117029 · Cited by 34
An, Y., Xu, W. J., Jin, X., He, W., Kim, H., Lee, J., & Park, S. (2012) · ACS Chemical Biology · doi:10.1021/cb3004226 · Cited by 52
Zhang, S., Liu, X., Wang, J., Yuan, F., & Liu, Y. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00852-7 · Cited by 36
“SIRT1 has been reported to confer widespread influence on several processes, and its dysregulation is closely related to the development of many diseases, including T2DM [45].”
BackgroundActivation and inhibition of sirtuins: From bench to bedside
Fiorentino, F., Fabbrizi, E., Mai, A., & Rotili, D. (2024) · Medicinal Research Reviews · doi:10.1002/med.22076 · Cited by 42
The Role of Molecular and Cellular Aging Pathways on Age-Related Hearing Loss
Ege, T., Tao, L., & North, B. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179705 · Cited by 44
“SIRT1, the most well studied, may regulate lifespan by deacetylating [157] proteins such as p53, NF-κ B, PGC-1 α , and FOXO3a [156,158] and offers protection against aging-related diseases by promoting glucose homeostasis and insulin sensitivity [159].”
Background
Metadata
- Authors
- Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., Bemis, J. E., Xie, R., Disch, J. S., Ng, P. Y., Nunes, J. J., Lynch, A. V., Yang, H., Galonek, H., Israelian, K., Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D. A., Olefsky, J. M., Jirousek, M. R., Elliott, P. J., & Westphal, C. H.
- Affiliations
- University of California San Diego (US)
- Harvard University (US)
- Corresponding author
- Westphal, Christoph H.
- ORCID
- Venue
- Nature
- Published
- 2007-11-29
- Volume
- 450
- Issue
- 7170
- Pages
- 712-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2753457
- OpenAlex
- W2116350182
- Cited by
- 1,707
- References
- 27
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 55 · 2023: 55 · 2022: 68 · 2021: 100 · 2020: 80 · 2019: 75 · 2018: 82 · 2017: 69 · 2016: 92 · 2015: 89 · 2014: 110 · 2013: 119 · 2012: 126
- FWCI
- 55.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging (P01AG027916, R01AG028730, R01AG019719)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- SIRT1, small molecule activators, type 2 diabetes, insulin resistance, caloric restriction mimetics, resveratrol, NAD+-dependent deacetylase, allosteric site, glucose homeostasis, mitochondrial function, obesity, aging, drug screening
- MeSH terms
- Resveratrol, Acetylation, Allosteric Site, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Type 2, Dietary Fats, Disease Models, Animal, Drosophila melanogaster, Heterocyclic Compounds, 4 or More Rings, Humans, Insulin, Male, Mitochondria, Rats, Zucker, Stilbenes, Rats, Sprague-Dawley, Catalytic Domain, Caloric Restriction, Sirtuins, Mice, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.